Moving forward in advanced bladder cancer
- PMID: 17538159
- DOI: 10.1200/JCO.2006.10.3630
Moving forward in advanced bladder cancer
Comment on
-
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.J Clin Oncol. 2007 Jun 1;25(16):2218-24. doi: 10.1200/JCO.2006.08.0994. J Clin Oncol. 2007. PMID: 17538166 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
